Downregulation of ADAMTS3 Suppresses Stemness and Tumorigenicity in Glioma Stem Cell

Glioblastoma multiforme (GBM) is the most aggressive type of human brain tumor, with a poor prognosis and a median overall survival of fewer than 15 months. Glioma stem cells (GSCs) have recently been identified as a key player in tumor initiation and therapeutic resistance in GBM. ADAMTS family of metalloproteinases is known to cleave a wide range of extracellular matrix substrates and has been linked to tissue remodeling events in tumor development. Here, we investigate that ADAMTS3 regulates GSC proliferation and self‐renewal activities, and tumorigenesis in orthotopic xenograft models.

[1]  Nandaraj Taye,et al.  Regulation of ADAMTS Proteases , 2021, Frontiers in Molecular Biosciences.

[2]  Jiumao Lin,et al.  Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  Sung-Hak Kim,et al.  B3GNT5 is a novel marker correlated with stem‐like phenotype and poor clinical outcome in human gliomas , 2020, CNS neuroscience & therapeutics.

[4]  Wei Wu,et al.  Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma , 2020, CNS neuroscience & therapeutics.

[5]  L. Neder,et al.  The immunohistochemical landscape of the VEGF family and its receptors in glioblastomas , 2020, Surgical and Experimental Pathology.

[6]  J. Rich,et al.  Glioblastoma Stem Cells: Driving Resilience through Chaos. , 2020, Trends in cancer.

[7]  Fu-sheng Liu,et al.  Formation of new lymphatic vessels in glioma: An immunohistochemical analysis , 2020, Neuropathology : official journal of the Japanese Society of Neuropathology.

[8]  Yan-wei Liu,et al.  RGS16 promotes glioma progression and serves as a prognostic factor , 2020, CNS neuroscience & therapeutics.

[9]  Runan Yao,et al.  ShinyGO: a graphical gene-set enrichment tool for animals and plants , 2019, Bioinform..

[10]  Jia Wang,et al.  Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma , 2019, CNS neuroscience & therapeutics.

[11]  T. Jiang,et al.  Molecular and clinical characterization of TMEM71 expression at the transcriptional level in glioma , 2019, CNS neuroscience & therapeutics.

[12]  F. Kockar,et al.  SP1-mediated downregulation of ADAMTS3 gene expression in osteosarcoma models. , 2018, Gene.

[13]  Yuehua Gong,et al.  VEGFC/VEGFR3 Signaling Regulates Mouse Spermatogonial Cell Proliferation via the Activation of AKT/MAPK and Cyclin D1 Pathway and Mediates the Apoptosis by affecting Caspase 3/9 and Bcl-2 , 2018, Cell cycle.

[14]  K. Alitalo,et al.  Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1 , 2017, Scientific Reports.

[15]  K. Alitalo,et al.  Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD. , 2016, The Journal of clinical investigation.

[16]  A. Colige,et al.  ADAMTS3 activity is mandatory for embryonic lymphangiogenesis and regulates placental angiogenesis , 2015, Angiogenesis.

[17]  Richard J. R. Kelwick,et al.  The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family , 2015, Genome Biology.

[18]  C. López-Otín,et al.  ADAMTS proteases and cancer. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[19]  Zuli Yang,et al.  The roles of ADAMTS in angiogenesis and cancer , 2015, Tumor Biology.

[20]  Rakesh K. Singh,et al.  VEGF-C-VEGFR3/Flt4 axis regulates mammary tumor growth and metastasis in an autocrine manner. , 2015, American journal of cancer research.

[21]  Qiulian Wu,et al.  Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy , 2014, Genes & development.

[22]  K. Alitalo,et al.  CCBE1 Enhances Lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3–Mediated Vascular Endothelial Growth Factor-C Activation , 2014, Circulation.

[23]  G. Taraboletti,et al.  Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms. , 2014, The American journal of pathology.

[24]  K. Hoang-Xuan,et al.  Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. , 2014, The New England journal of medicine.

[25]  Se Hoon Kim,et al.  Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. , 2013, Cancer cell.

[26]  G. Smyth,et al.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.

[27]  J. McNamara.  Cancer Stem Cells , 2007, Methods in Molecular Biology.

[28]  M. Hung,et al.  The role of the VEGF-C/VEGFR-3 axis in cancer progression , 2006, British Journal of Cancer.

[29]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[30]  K. Powell,et al.  Regulation of procollagen amino-propeptide processing during mouse embryogenesis by specialization of homologous ADAMTS proteases: insights on collagen biosynthesis and dermatosparaxis , 2006, Development.

[31]  K. Hoang-Xuan,et al.  Primary brain tumours in adults , 2003, The Lancet.

[32]  D. Eyre,et al.  Procollagen II Amino Propeptide Processing by ADAMTS-3 , 2001, The Journal of Biological Chemistry.